Before there was HempWorx, there was My Daily Choice, an MLM whose main products pre-HempWorx were supplements that you spray into your mouth. Josh Zwagil started My Daily Choice in November 2014, a month after ending a five-year run with an automotive products MLM, Syntek Global, where he rose to the highest rank of Blue Diamond Executive, according to his LinkedIn page. (Fun fact: After Zwagil left Syntek Global, the MLM filed a lawsuit against its longtime president, John Winterholler, alleging, among other things, that he went behind the company’s back and against its interests to market and sell a competitor’s products.)
I am a user of Hempworx products and cannot day enough good things about them. I take the oil 2x a day for anxiety and a couple of other health issues. Taking it at night helps with my restless leg syndrome so I can sleep soundly. I also use the Relief pain rub and it’s amazing. Post surgery on my wrist I applied it near, but not on, my incision site and it made such a difference. I never took the first pain pill. In the interest of full disclosure I will also state that I am an Independent Affiliate and sell the products. However, prior to that I was only a user. I recommend everyone try this as an alternative to pills.
Several of the cannabinoids are reputed to have medicinal potential: THC for glaucoma, spasticity from spinal injury or multiple sclerosis, pain, inflammation, insomnia, and asthma; CBD for some psychological problems. The Netherlands firm HortaPharm developed strains of Cannabis rich in particular cannabinoids. The British firm G.W. Pharmaceuticals acquired proprietary access to these for medicinal purposes, and is developing medicinal marijuana. In the US, NIH (National Institute of Health) has a program of research into medicinal marijuana, and has supplied a handful of individuals for years with maintenance samples for medical usage. The American Drug Enforcement Administration is hostile to the medicinal use of Cannabis, and for decades research on medicinal properties of Cannabis in the US has been in an extremely inhospitable climate, except for projects and researchers concerned with curbing drug abuse. Synthetic preparations of THC—dronabinol (Marinol®) and nabilone (Cesamet®)—are permitted in some cases, but are expensive and widely considered to be less effective than simply smoking preparations of marijuana. Relatively little material needs to be cultivated for medicinal purposes (Small 1971), although security considerations considerably inflate costs. The potential as a “new crop” for medicinal cannabinoid uses is therefore limited. However, the added-value potential in the form of proprietary drug derivatives and drug-delivery systems is huge. The medicinal efficacy of Cannabis is extremely controversial, and regrettably is often confounded with the issue of balancing harm and liberty concerning the proscriptions against recreational use of marijuana. This paper is principally concerned with the industrial uses of Cannabis. In this context, the chief significance of medicinal Cannabis is that, like the issue of recreational use, it has made it very difficult to rationally consider the development of industrial hemp in North America for purposes that everyone should agree are not harmful.
France is Europe's biggest producer (and the world's second largest producer) with 8,000 hectares (20,000 acres) cultivated. 70–80% of the hemp fibre produced in 2003 was used for specialty pulp for cigarette papers and technical applications. About 15% was used in the automotive sector, and 5-6% was used for insulation mats. About 95% of hurds were used as animal bedding, while almost 5% was used in the building sector. In 2010/2011, a total of 11,000 hectares (27,000 acres) was cultivated with hemp in the EU, a decline compared with previous year.
Cannabidiol (CBD) is a naturally occurring compound found in the resinous flower of cannabis, a plant with a rich history as a medicine going back thousands of years. Today the therapeutic properties of CBD are being tested and confirmed by scientists and doctors around the world. A safe, non-addictive substance, CBD is one of more than a hundred “phytocannabinoids,” which are unique to cannabis and endow the plant with its robust therapeutic profile.
They allege you can earn up to seven figures per month depending on your rank. But if you look on page 12 of their terms and conditions, they say that any amounts reflected on their website is for demonstration purposes only and does not mean anything in terms of earning commissions. Seems like they are throwing these huge numbers around to try and get you to join.
As you comb through the web pages, it’s clear the product is meant for a multi-level marketing scheme. Many of these companies do not expect anyone to actually use the product. They just want people who will buy it in hopes of selling it to someone else. One previous potential customer has said he could not buy the product, as the company demanded a referral. This means multi-level marketing might be their main business. This can lead to problems getting the product for regular consumers, though they do have an option to sell directly to the consumer as well on the website.
Hemp stalk is baled for transportation and long-term storage using traditional farming balers. Large round balers are best for hemp because they allow for more thorough drying as they don’t pack the hemp as tightly as square balers. Hemp should be stored in a dry environment in conditions intended to reduce as much absorbable air moisture as possible. It’s also important to check for wet patches during baling to further avoid mold.
"Skunk" refers to several named strains of potent cannabis, grown through selective breeding and sometimes hydroponics. It is a cross-breed of Cannabis sativa and C. indica (although other strains of this mix exist in abundance). Skunk cannabis potency ranges usually from 6% to 15% and rarely as high as 20%. The average THC level in coffee shops in the Netherlands is about 18–19%.
Early this month, the FDA just approved a new drug for depression called esketamine. Esketamine, marketed under the brand name Spravato, is a ketamine-based drug designed for patients who aren’t responding to conventional antidepressant medications. It comes in a nasal spray form, and is touted to be the world’s first quick-relief depression medication in the market.
Industrial hemp is from the plant species Cannabis sativa and has been used worldwide to produce a variety of industrial and consumer products. Hemp is a source of fiber and oilseed grown in more than 30 nations. In the United States production is controlled under drug enforcement laws. To produce industrial hemp in the United States the grower must obtain a permit from the Drug Enforcement Agency (DEA).
Hemp plants can be vulnerable to various pathogens, including bacteria, fungi, nematodes, viruses and other miscellaneous pathogens. Such diseases often lead to reduced fiber quality, stunted growth, and death of the plant. These diseases rarely affect the yield of a hemp field, so hemp production is not traditionally dependent on the use of pesticides.
Cannabis use started to become popular in the United States in the 1970s. Support for legalization has increased in the United States and several U.S. states have legalized recreational or medical use. A 2018 Social Science Research study found that the main determinants of such changes in attitudes toward marijuana regulation since the 1990s were changes in media framing of marijuana, a decline in perception of the riskiness of marijuana, a decline in overall punitiveness, and a decrease in religious affiliation.